SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-142735
Filing Date
2021-04-30
Accepted
2021-04-30 08:30:52
Documents
2
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d176669ddef14a.htm DEF 14A 371520
2 GRAPHIC g176669g08a88.jpg GRAPHIC 33657
  Complete submission text file 0001193125-21-142735.txt   413517
Mailing Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39460 | Film No.: 21873910
SIC: 2836 Biological Products, (No Diagnostic Substances)